N-3 Fatty Acids and Cardiovascular Disease.
From: Rockefeller University, New York, NY 10021, USA. breslow@rockefeller.edu
The American journal of clinical nutrition
- Publish Date: Jun 2006
- ISSN: 0002-9165
- Volume: 83
- Issue: 6 Suppl
- Pages: 1477S-1482S
- Medium: Print
- Language: English
- Citation (JAMA): Breslow Jan L, et al. N-3 Fatty Acids and Cardiovascular Disease.. Am. J. Clin. Nutr. Jun 2006;83:1477S-1482S
Abstract
The results of prospective cohort studies indicate that consuming fish or fish oil containing the n-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) is associated with decreased cardiovascular death, whereas consumption of the vegetable oil-derived n-3 fatty acid a-linolenic acid is not as effective. Randomized control trials (RCTs) in the context of secondary prevention also indicate that the consumption of EPA plus DHA is protective at doses <1 g/d. The therapeutic effect appears to be due to suppression of fatal arrhythmias rather than stabilization of atherosclerotic plaques. At doses >3 g/d, EPA plus DHA can improve cardiovascular disease risk factors, including decreasing plasma triacylglycerols, blood pressure, platelet aggregation, and inflammation, while improving vascular reactivity. Mainly on the basis of the results of RCTs, the American Heart Association recommends that everyone eat oily fish twice per week and that those with coronary heart disease eat 1 g/d of EPA plus DHA from oily fish or supplements. Directions for future research include (1) RCTs to confirm the initial trials showing that EPA plus DHA decreases cardiovascular death and additional studies to determine whether this effect is due to EPA, DHA, or the combination; the dosage of the effective components; and whether the mechanism of action in humans is prevention of fatal arrhythmias. (2) Clinical studies to determine whether the reduction in cardiovascular disease risk factors is due to EPA, DHA, or the combination and the dosage of the effective components. (3) Clinical studies to determine whether vegetable oil-derived alpha-linolenic acid added to a diet enriched in n-6 fatty acids can effectively substitute for fish oil-derived EPA plus DHA.
Mesh Headings (Keywords): Arrhythmias, Cardiac, Cardiovascular Diseases, Docosahexaenoic Acids, Dose-Response Relationship, Drug, Drug Synergism, Eicosapentaenoic Acid, Fatty Acids, Omega-3, Fish Oils, Humans, Nutrition Policy, Randomized Controlled Trials as Topic, Risk Factors, alpha-Linolenic Acid
Check for Full Text / PubMed Unique Identifier (PMID): 16841857
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.